Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants
Jeff Min, Dina Appleby, Robyn L. McClelland, et al.
Annals of the American Thoracic Society (2021) Vol. 19, Iss. 6, pp. 952-961
Open Access | Times Cited: 20

Showing 20 citing articles:

Treatment of pulmonary arterial hypertension: recent progress and a look to the future
Marc Humbert, Olivier Sitbon, Christophe Guignabert, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 9, pp. 804-819
Closed Access | Times Cited: 59
Minimal Clinically Important Difference in the 6-minute-walk Distance for Patients with Pulmonary Arterial Hypertension
Jude Moutchia, Robyn L. McClelland, Nadine Al‐Naamani, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 8, pp. 1070-1079
Closed Access | Times Cited: 41
Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis
Jude Moutchia, Robyn L. McClelland, Nadine Al‐Naamani, et al.
European Heart Journal (2024) Vol. 45, Iss. 21, pp. 1937-1952
Closed Access | Times Cited: 9
Is low-risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomised trials
Bryan S. Blette, Jude Moutchia, Nadine Al‐Naamani, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 10, pp. 873-882
Open Access | Times Cited: 19
Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension
Jason Weatherald, Thomas R. Fleming, Martin R. Wilkins, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401205-2401205
Open Access | Times Cited: 7
Clinical Response to PAH Treatment Does Not Depend on Pulmonary Artery Wedge Pressure – A Meta-Analysis Using Individual Participant Data from Randomized Clinical Trials
Gábor Kovács, Jude Moutchia, Katarina Zeder, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 6, pp. 844-847
Closed Access | Times Cited: 5
Medications for the treatment of pulmonary arterial hypertension: a systematic review and network meta-analysis
Tyler Pitre, Johnny Su, Sonya Cui, et al.
European Respiratory Review (2022) Vol. 31, Iss. 165, pp. 220036-220036
Open Access | Times Cited: 20
PULMONARY ARTERIAL HYPERTENSION IN LATIN AMERICA. THE AGE AND COMORBIDITY PARADOX
Tomás Pulido, Sofía De la Cruz‐Pérez, Daphne I Valencia, et al.
International Journal of Cardiology Congenital Heart Disease (2025) Vol. 19, pp. 100573-100573
Open Access
Racial and Ethnic Equity in Pulmonary Arterial Hypertension Clinical Trials
Tijana Milinic, Peter J. Leary, Lia M. Barros
Advances in Pulmonary Hypertension (2025) Vol. 23, Iss. 2, pp. 59-63
Open Access
Novel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension
Jacqueline V. Scott, Jude Moutchia, Robin L McClelland, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 8, pp. 1045-1056
Closed Access | Times Cited: 3
Heterogeneity of treatment effects by risk in pulmonary arterial hypertension
Hao‐Min Pan, Robyn L. McClelland, Jude Moutchia, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 1, pp. 2300190-2300190
Closed Access | Times Cited: 7
BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension
Breanne E. McCarthy, Robyn L. McClelland, Dina Appleby, et al.
CHEST Journal (2022) Vol. 162, Iss. 2, pp. 436-447
Open Access | Times Cited: 9
Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension
Jasleen Minhas, Jude Moutchia, Nadine Al‐Naamani, et al.
Annals of the American Thoracic Society (2024) Vol. 21, Iss. 6, pp. 858-865
Closed Access | Times Cited: 1
Health Care Disparities in Pulmonary Arterial Hypertension
Roberto J. Bernardo, Vinicio A. de Jesús Pérez
Clinics in Chest Medicine (2023) Vol. 44, Iss. 3, pp. 543-554
Closed Access | Times Cited: 3
Novel Liver Injury Phenotypes and Outcomes in Pulmonary Arterial Hypertension
Jacqueline V. Scott, Jude Moutchia, Robin L McClelland, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Extrapulmonary manifestations of pulmonary arterial hypertension
Navneet Singh, Nadine Al‐Naamani, Mary Beth Brown, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 3-4, pp. 189-205
Closed Access
Full Issue PDF

Advances in Pulmonary Hypertension (2023) Vol. 22, Iss. 2, pp. 1-36
Open Access
Socioeconomic and Social Determinants of Health: Effects on Pulmonary Arterial Hypertension Care
Roberto J. Bernardo, Arun Jose, Jean Elwing
Advances in Pulmonary Hypertension (2023) Vol. 22, Iss. 2, pp. 111-117
Open Access
Long-term impact of add-on sequential triple combination therapy in pulmonary arterial hypertension: real world experience
Himanshu Deshwal, Tatiana Weinstein, Rachel Salyer, et al.
Therapeutic Advances in Respiratory Disease (2023) Vol. 17
Open Access
Lungenerkrankungen
Vera Regitz‐Zagrosek
Springer eBooks (2023), pp. 181-191
Closed Access
Page 1

Scroll to top